https://www.prnewswire.com/news-releases/janssen-submits-new-drug-application-to-us-fda-for-simeprevir-tmc435-for-combination-treatment-of-adult-patients-with-genotype-1-chronic-hepatitis-c-200501671.html
Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment...
https://www.jnj.com/media-center/press-releases/janssen-files-first-regulatory-application-for-simeprevir-tmc435-for-the-treatment-of-genotype-1-hepatitis-c-patients-in-japan
Janssen Files First Regulatory Application for Simeprevir (TMC435) for the Treatment of Genotype 1...
https://www.jnj.com/media-center/press-releases/simeprevir-data-from-cosmos-study-in-hepatitis-c-patients-accepted-as-late-breaking-presentation-at-the-annual-meeting-of-the-american-association-for-the-study-of-liver-diseases-aasld
Simeprevir Data from COSMOS study in Hepatitis C Patients Accepted as Late-Breaking Presentation at...
https://www.goodrx.com/olysio/what-is
Olysio (simeprevir): Drug Basics and Frequently Asked Questions
Learn about Olysio (simeprevir), including frequently asked questions about the medication.
frequently askedolysiosimeprevirdrugbasics